Products

TRAQinform IQ
AIQ Global
Oncology AI
TRAQinform IQ is an FDA-cleared, cloud-based AI software tool that provides quantitative analysis of lesions in PET/CT scans, aiding clinicians in monitoring disease progression and treatment response in oncology and nuclear medicine.

See all 1 product →

About AIQ Global

AIQ Solutions is a healthcare artificial intelligence company dedicated to enhancing treatment outcomes for patients grappling with complex diseases, with a particular focus on late-stage cancer care. The company comprises a team of entrepreneurs, scientists, and engineers who leverage a strong foundation of intellectual property and rigorous clinical validation to innovate how clinicians manage these challenging conditions.

Their core offering, TRAQinform IQ, is a software medical device cleared by the FDA for clinical use. This technology provides novel information by quantifying changes in regions of interest over time from serial radiographic images. This capability empowers oncologists and other clinicians to more precisely adjust therapies and optimize clinical outcomes. Studies have indicated that AIQ Solutions’ technology is more prognostic of overall survival compared to standard-of-care methods in patients with metastatic lung cancer and lymphoma, by analyzing lesion-level changes and treatment response heterogeneity.

Focus Areas

Late-stage cancer care lesion-level longitudinal quantitative imaging imaging biomarker development quantitative image analysis and radiomics longitudinal lesion-level response assessment AI/ML-driven predictive analytics for treatment response cloud-based medical image data management therapy/tracer development for pharma and radiopharma companies

Business Intelligence

Key InvestorsCapital Midwest Fund, Rock River Capital Partners, 30Ventures, WARF Ventures, NVNG, Tundra Angels, BrightStar Wisconsin Foundation
PartnershipsBlackford Analysis, Scientist.com, Flywheel, University of Western Australia, Sir Charles Gairdner Hospital, Edith Cowan University, Rocky Mountain Cancer Center
TechnologyTRAQinform IQ (software medical device), cloud-based HIPAA-compliant data pipelines, automated report generation, quantitative imaging algorithms, AI/machine learning for predictive modeling, research data management platform integration
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

Late-Stage Cancer Care Optimization
Specializes in optimizing care for patients with late-stage cancers, particularly by addressing intra-patient heterogeneity where individual lesions may respond differently to therapy.
Lesion-Level Longitudinal Quantitative Imaging
Utilizes TRAQinform IQ technology to provide novel quantification of changes in regions of interest over time from serial radiographic images (e.g., PET, CT).
Imaging Biomarker Development & Radiomics
Expertise in developing imaging biomarkers, quantitative image analysis, and radiomics, leveraging AI and advanced image processing algorithms to extract meaningful insights.
AI/ML-Driven Predictive Analytics
Applies AI/ML-driven predictive analytics for treatment response, with AI-assisted analysis helping to predict disease response and provide clinical decision support.
Cloud-Based Medical Image Data Management
Offers a cloud-based, HIPAA-compliant, and secure system (TRAQinform IQ) for processing 3D medical images and managing data.
Therapy/Tracer Development Support
Provides services for pharma and radiopharma companies to accelerate therapy and radiotracer development by analyzing radiological imaging scans to understand treatment response heterogeneity and toxicity risk.
Physician Tip

AIQ Solutions' TRAQinform IQ technology offers physicians a powerful tool to enhance late-stage cancer care. It provides more precise, lesion-level insights into treatment response and intra-patient heterogeneity, which can lead to more confident and personalized treatment decisions. The automation of complex image analysis significantly reduces manual review time, allowing physicians to focus more on patient care. Furthermore, its superior prognostic value compared to standard methods can aid in better predicting patient outcomes and adjusting therapies proactively. The FDA clearance ensures reliability and clinical readiness.

AIQ Solutions' TRAQinform IQ technology is designed for easy integration into existing clinical workflows, including hospital networks for data transfer and electronic medical record (EMR) systems for seamless report access. They also have a commercial partnership with Blackford Analysis to integrate their technology with Blackford's advanced enterprise AI platform, expanding reach to more clinicians.

Products by AIQ Global

1 product in the directory

TRAQinform IQ
AIQ Global
Oncology AI
TRAQinform IQ is an FDA-cleared, cloud-based AI software tool that provides quantitative analysis of lesions in PET/CT scans, aiding clinicians in monitoring disease progression and treatment response in oncology and nuclear medicine.

Reviews & Opinions

No web reviews on file yet for AIQ Global. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about AIQ Global.

Loading videos...

Videos load interactively. If none appear, search YouTube for AIQ Global →

View all on YouTube

Press & Coverage

PR Newswire
AiQ Launches Enterprise AI Platform for the U.S. Market with Support from EntryPoint Boston
AiQ announced its expansion into the U.S. market and the launch of its Enterprise AI platform, designed to help organizations improve search accuracy, build AI agents, and automate workflows by connecting data across the enterprise.
2026-04
AIQA Global
AIQA Global Names Maria Ross Chief Operating Officer
AIQA Global, an independent AI governance rating firm, appointed Maria Ross as Chief Operating Officer to bring the AIQu2122 score as an industry standard for AI governance quality to carriers, brokers, and reinsurers.
2026-05
AIQ Global
AIQ Solutions Announces a New Category III CPT Code for Determining Heterogeneity of Change Across All Lesions for Advanced Metastatic Cancer Used with TRAQinform IQ Technology
AIQ Solutions received approval for a new Category III CPT code from the American Medical Association (AMA) for its TRAQinform IQ technology, which provides advanced treatment response intelligence for metastatic cancer.
2026-04
MarketScreener
AIQ Limited announced that it expects to receive u00a32 million in funding from Central China International Securities Co., Ltd.
AIQ Limited entered into a convertible loan note agreement with Central China International Securities Co., Ltd. for up to u00a32 million in unsecured, interest-free convertible loan notes.
2026-07
AIQ
AIQ enters Oman with agreement to accelerate AI adoption in the Sultanate's Oil & Gas sector, in partnership with Ras Al Hamra LLC.
AIQ has expanded into Oman through a partnership with Ras Al Hamra LLC, aiming to accelerate AI adoption within the Sultanate's Oil & Gas sector.
2026-05
PR Newswire
Clinicians Are Adopting AI to Solve the Documentation Crisis, New Global Survey Finds
A global survey revealed that 86% of clinicians are using AI daily or several times a week to manage administrative burdens, even though 83% lack formal guidance from their employers.
2026-07
Health Policy Watch
As Artificial Intelligence Drives Health Innovations, UN Agencies Launch Joint Strategic Guidelines
Three UN agencies (WHO, ITU, WIPO) launched a landmark framework at the 'AI for Good' Global Summit, providing strategic guidelines for health innovators to navigate intellectual property, data governance, and regulatory pathways for AI.
2026-07
ScienceDaily
AI flags more than 250,000 suspicious cancer research papers
A new AI tool analyzed 2.6 million cancer research papers and identified over 250,000 studies with writing patterns indicative of fraudulent 'paper mills,' highlighting a significant integrity problem in modern science.
2026-07

Frequently Asked Questions

AIQ Solutions' TRAQinform IQu2122 software provides lesion-level longitudinal quantitative imaging, enabling precise measurement of changes in individual lesions over time. This approach helps oncologists understand treatment response heterogeneity, offering more prognostic information than traditional methods for optimizing therapy in late-stage cancer patients.
AIQ Solutions offers cloud-based lesion-level image analysis and reporting, ensuring secure and HIPAA-compliant data management. Their technology is designed for easy integration into existing workflows, utilizing serial radiographic images like PET and CT, and delivers comprehensive reports to clinicians.
Yes, AIQ Solutions specializes in imaging biomarker development, quantitative image analysis, and radiomics. The platform leverages AI/ML-driven predictive analytics to help identify disease response and toxicity risk, supporting the discovery and validation of novel biomarkers for personalized treatment strategies.
AIQ Solutions' software is FDA 510(k) cleared for clinical use, demonstrating adherence to regulatory standards. They utilize secure, cloud-based HIPAA-compliant data pipelines to ensure the privacy and security of medical image data.
AIQ Solutions provides services to pharma and radiopharma companies, accelerating therapy and tracer development by enabling research scientists to better understand treatment response heterogeneity and toxicity risk through radiological imaging scans. They are a registered supplier on Scientist.com, facilitating collaborations for clinical trials and biomarker development.
AIQ Solutions' cloud-based platform is designed for easy integration into existing workflows, requiring minimal on-site IT burden. While specific pricing models are not publicly detailed, cloud solutions typically offer flexible subscription or per-study arrangements tailored to the scale of clinical or research use.
AIQ Solutions is committed to continuous innovation, leveraging a strong foundation of intellectual property and rigorous clinical validation to improve treatment outcomes for complex diseases. They actively engage in research collaborations and partnerships to expand their reach and advance clinical care.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.